Healthcare - Biotechnology - NASDAQ - US
$ 25.05
-12 %
$ 3.61 B
Market Cap
-9.08
P/E
BALANCE SHEET
1.15 B
ASSETS
123 M
LIABILITIES
1.03 B
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Denali Therapeutics Inc.
| Current Assets | 1.06 B |
| Cash & Short-Term Investments | 1.03 B |
| Receivables | 3.42 M |
| Other Current Assets | 26.2 M |
| Non-Current Assets | 89.8 M |
| Long-Term Investments | 0 |
| PP&E | 71.6 M |
| Other Non-Current Assets | 18.1 M |
| Current Liabilities | 78 M |
| Accounts Payable | 9.48 M |
| Short-Term Debt | 7.26 M |
| Other Current Liabilities | 61.2 M |
| Non-Current Liabilities | 45 M |
| Long-Term Debt | 45 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Cash & Cash Equivalents | 127.1 | 218.0 | 293.5 | 507.1 | 79.4 | 77.1 | 218.4 | 39.9 | 30.7 |
| Short Term Investments | 907.4 | 1 118.2 | 571.9 | 962.6 | 335.9 | 387.2 | 187.9 | 138.5 | 0 |
| Receivables | 3.4 | 9.3 | 1.2 | 0 | 0 | 8.5 | 0.5 | 0.4 | 0 |
| Inventory | 0 | (5.0) | 0 | 0 | 0 | (8.5) | (0.5) | 0 | 0 |
| Other Current Assets | 26.2 | 26.8 | 30.6 | 20.3 | 29.4 | 8.0 | 1.9 | 0.6 | 66 K |
| Total Current Assets | 1 064.1 | 1 372.3 | 897.2 | 1 495.7 | 430.0 | 480.8 | 409.6 | 182.0 | 33.4 |
| PP&E | 71.6 | 74.5 | 69.6 | 73.5 | 80.7 | 25.2 | 14.9 | 15.3 | 3.2 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 1.5 | 425.4 | 32.7 | 39.9 | 147.9 | 60.8 | 73.1 | 84 K |
| Other Long Term Assets | 18.1 | 11.9 | 11.9 | 2.5 | 2.7 | 8.1 | 1.4 | 0.8 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 1 153.9 | 1 460.2 | 1 404.2 | 1 604.3 | 553.2 | 662.0 | 486.7 | 271.1 | 36.7 |
| LIABILITIES | |||||||||
| Accounts Payable | 9.5 | 2.8 | 4.8 | 1.1 | 2.6 | 1.9 | 2.7 | 2.0 | 1.7 |
| Short Term Debt | 7.3 | 7.3 | 5.5 | 4.7 | 3.7 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 61.2 | 63.8 | 47.7 | 42.5 | 20.4 | 19.5 | 11.4 | 7.1 | 1.8 |
| Total Current Liabilities | 78.0 | 363.9 | 378.2 | 71.7 | 45.3 | 32.8 | 14.2 | 9.1 | 3.5 |
| Long Term Debt | 45.0 | 53.0 | 58.6 | 64.2 | 68.9 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0.4 | 0.4 | 0.7 | 0.4 | 25.0 | 6.8 | 7.4 | 48.8 |
| Total Liabilities | 123.0 | 417.8 | 441.9 | 453.7 | 158.3 | 115.1 | 20.9 | 16.5 | 52.3 |
| EQUITY | |||||||||
| Common Stock | 1.7 | 1.7 | 1.5 | 1.5 | 1.3 | 1.3 | 1.2 | 2.7 | 0.2 |
| Retained Earnings | (1 116.2) | (971.0) | (645.0) | (354.4) | (425.6) | (227.9) | (191.7) | (103.5) | (16.9) |
| Other Accumulative Comprehensive Income/Loss | 0.6 | (6.9) | (2.5) | (0.2) | 0.3 | (0.6) | (0.4) | (0.4) | (48.3) |
| Total Equity | 1 031.0 | 1 042.4 | 962.3 | 1 150.5 | 394.9 | 546.8 | 465.8 | 254.5 | (15.6) |
| Total Liabilities and Equity | 1 153.9 | 1 460.2 | 1 404.2 | 1 604.3 | 553.2 | 662.0 | 486.7 | 271.1 | 36.7 |
| SHARES OUTSTANDING | |||||||||
| Common Shares Outstanding | 137.4 | 125.5 | 121.5 | 109.0 | 95.6 | 92.6 | 15.0 | 6.4 | 3.0 |